Germany
Japan
United Kingdom
China
ESR1 (Myc-DDK-tagged)-Human estrogen receptor 1 (ESR1), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
B Cell Lineage
CEBPB (untagged)-Human CCAAT/enhancer binding protein (C/EBP), beta (CEBPB)
| Vector | pCMV6-AC |
| Tag | Tag Free |
| Mammalian Cell Selection | Neomycin |
IL6 (Myc-DDK-tagged)-Human interleukin 6 (interferon, beta 2) (IL6)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
USD 390.00
In Stock
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HC10, Purified
| Applications | ELISA, EM, FC, IF, IHC, IP, WB |
| Reactivities | Human |
qSTAR qPCR primer pairs against Mus musculus gene Tnf
ESR2 (Myc-DDK-tagged)-Human estrogen receptor 2 (ER beta) (ESR2), transcript variant a
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
ESR1 (untagged)-Human estrogen receptor 1 (ESR1), transcript variant 1
| Vector | pCMV6-XL4 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
CRP mouse monoclonal antibody, clone PC1, Purified
| Applications | ELISA, WB |
| Reactivities | Porcine |
IL6ST (Myc-DDK-tagged)-Human interleukin 6 signal transducer (gp130, oncostatin M receptor) (IL6ST), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
TNF (Myc-DDK-tagged)-Human tumor necrosis factor (TNF)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
IL1B (Myc-DDK-tagged)-Human interleukin 1, beta (IL1B)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
USD 475.00
2 Weeks
qSTAR qPCR primer pairs against Homo sapiens gene IL6
| Component | 1 vial of lyophilized qSTAR qPCR primer mix (1 nmol each primer, sufficient for 200 reactions) |
IL37 (Myc-DDK-tagged)-Human interleukin 1 family, member 7 (zeta) (IL1F7), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
qSTAR qPCR primer pairs against Mus musculus gene Il6
HSPA9 (Myc-DDK-tagged)-Human heat shock 70kDa protein 9 (mortalin) (HSPA9), nuclear gene encoding mitochondrial protein
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CASP1 (Myc-DDK-tagged)-Human caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) (CASP1), transcript variant alpha
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
IL1B (untagged)-Human interleukin 1, beta (IL1B)
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
Cebpb (Myc-DDK-tagged) - Mouse CCAAT/enhancer binding protein (C/EBP), beta (Cebpb)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
CEBPB (Myc-DDK-tagged)-Human CCAAT/enhancer binding protein (C/EBP), beta (CEBPB)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
IL6R (Myc-DDK-tagged)-Human interleukin 6 receptor (IL6R), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
IL18 (Myc-DDK-tagged)-Human interleukin 18 (interferon-gamma-inducing factor) (IL18)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
IL1A (Myc-DDK-tagged)-Human interleukin 1, alpha (IL1A)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
HLA (Myc-DDK-tagged)-Human major histocompatibility complex, class II, DR beta 1 (HLA-DRB1)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CSRP1 (Myc-DDK-tagged)-Human cysteine and glycine-rich protein 1 (CSRP1), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
HLA (Myc-DDK-tagged)-Human major histocompatibility complex, class II, DR alpha (HLA-DRA)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
TOLLIP (Myc-DDK-tagged)-Human toll interacting protein (TOLLIP)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
RFX3 (Myc-DDK-tagged)-Human regulatory factor X, 3 (influences HLA class II expression) (RFX3), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
AGBL2 (Myc-DDK-tagged)-Human ATP/GTP binding protein-like 2 (AGBL2)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
IL1R1 (Myc-DDK-tagged)-Human interleukin 1 receptor, type I (IL1R1)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
GNAO1 (Myc-DDK-tagged)-Human guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O (GNAO1), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
HLA Class I ABC mouse monoclonal antibody, clone W6/32, FITC
| Applications | FC |
| Reactivities | Bovine, Feline, Human, Primate |
| Conjugation | FITC |
Il18 (Myc-DDK-tagged) - Mouse interleukin 18 (Il18)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
USD 1,020.00
3 Weeks
Lenti ORF particles, HLA (mGFP-tagged) - Human major histocompatibility complex, class I, E (HLA-E), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Buy this product and get 50% off on the Lenti RapidTiter kit. Use Code: Rapid50
CD74 (Myc-DDK-tagged)-Human CD74 molecule, major histocompatibility complex, class II invariant chain (CD74), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
IL1RAP (Myc-DDK-tagged)-Human interleukin 1 receptor accessory protein (IL1RAP), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CCNL2 (Myc-DDK-tagged)-Human cyclin L2 (CCNL2), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
ESR2 (untagged)-Human estrogen receptor 2 (ER beta) (ESR2), transcript variant a
| Vector | pCMV6-XL4 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
SC119216 is the updated version of SC119215.
qSTAR qPCR primer pairs against Homo sapiens gene TNF
| Component | 1 vial of lyophilized qSTAR qPCR primer mix (1 nmol each primer, sufficient for 200 reactions) |
HLA (Myc-DDK-tagged)-Human major histocompatibility complex, class I, E (HLA-E)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
IL1F10 (Myc-DDK-tagged)-Human interleukin 1 family, member 10 (theta) (IL1F10), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
ESR1 (Myc-DDK-tagged)-Human estrogen receptor 1 (ESR1), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
HLA Class II DR mouse monoclonal antibody, clone L243, Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Canine, Human, Primate |
CSRP3 (Myc-DDK-tagged)-Human cysteine and glycine-rich protein 3 (cardiac LIM protein) (CSRP3), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
HLA (Myc-DDK-tagged)-Human major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CEBPD (Myc-DDK-tagged)-Human CCAAT/enhancer binding protein (C/EBP), delta (CEBPD)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
HFE (Myc-DDK-tagged)-Human hemochromatosis (HFE), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
HLA (Myc-DDK-tagged)-Human major histocompatibility complex, class II, DP beta 1 (HLA-DPB1)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
RFX1 (Myc-DDK-tagged)-Human regulatory factor X, 1 (influences HLA class II expression) (RFX1)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
IL33 (Myc-DDK-tagged)-Human interleukin 33 (IL33), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
Filter by
Target Symbol
- IL6 (279)
- TNF (215)
- IL1RL1 (188)
- ESR1 (171)
- IL1RN (159)
- HFE (135)
- IL1B (133)
- ESR2 (130)
- CASP1 (124)
- IL1RAP (119)
- AGTPBP1 (100)
- CRP (98)
- IL33 (92)
- IL1A (87)
- IL6ST (85)
- IL1R2 (79)
- CEBPB (78)
- AGBL5 (72)
- CCPG1 (72)
- CSRP3 (71)
- IL18 (70)
- CSRP1 (69)
- ENTPD6 (66)
- IL1F10 (66)
- TOLLIP (66)
- IL1R1 (63)
- IL6R (63)
- CSRP2 (62)
- IL37 (62)
- IL18R1 (61)
- RAB3IL1 (61)
- TMED1 (61)
- AGBL4 (60)
- CRYGD (60)
- CCNL2 (58)
- CD74 (58)
- STK19 (58)
- CRIP2 (57)
- IL36RN (56)
- CRIP1 (55)
- CEBPD (54)
- CEBPE (53)
- ARHGAP45 (51)
- IL36A (51)
- SIGIRR (50)
- CALR (49)
- IL36G (49)
- CCDC115 (48)
- CCP110 (48)
- HLA-A (47)
- IL18RAP (47)
- IL1RL2 (46)
- RFX3 (46)
- HLA (45)
- RFX5 (44)
- AGBL3 (43)
- CRIP3 (42)
- HLA-F (41)
- RFX2 (41)
- AGBL2 (38)
- IL1RAPL2 (38)
- IL36B (37)
- IRAK1 (37)
- RFX4 (36)
- HLA-DQA2 (34)
- IL1RAPL1 (34)
- GZMH (33)
- HLA-DRB1 (33)
- GNAO1 (32)
- HLA-DQB1 (32)
- HLA-B (31)
- HLA-DPA1 (31)
- HSPA9 (30)
- HLA-DRA (29)
- IL1F5 (29)
- KAT14 (29)
- LMO4 (29)
- HLA-DPB1 (28)
- HLA-C (26)
- HLA-DQA1 (26)
- HLA-DRB4 (26)
- HLA-DRB5 (26)
- HLA-E (26)
- RFX1 (26)
- HLA-DOA (25)
- HLA-DOB (25)
- HLA-DRB3 (25)
- CSRP2BP (24)
- GZMC (24)
- AGBL1 (23)
- GZMF (23)
- HLA-G (22)
- BAG6 (21)
- IL6RA (21)
- HLA-DMA (20)
- HLA-DMB (20)
- PUM3 (19)
- A1CF (18)
- HLA-DQB2 (18)
- MYO1G (18)
Reactivities
Applications
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Expression Hosts
Lentivirus
Tags
Vectors
- pCMV6-Entry (737)
- pLenti-C-Myc-DDK-P2A-Puro (706)
- pLenti-C-mGFP-P2A-Puro (703)
- pGFP-C-shLenti (460)
- pCMV6-AC-GFP (313)
- pRS (236)
- pLenti-C-mGFP (154)
- EF1a-GFP-P2A-Puro (134)
- pLenti-C-Myc-DDK (109)
- pCMV6-XL5 (75)
- pGFP-V-RS (25)
- pCMV6-AC (24)
- PCMV6-Kan/Neo (22)
- pCMV6-XL4 (21)
- pRFP-C-RS (10)
- GFP-puro (8)
- Luciferase-Puro (8)
- RFP-BSD (8)
- mBFP-Neo (8)
- PCMV6-Neo (1)
- pCMV6-XL6 (1)
Reporters
Modifications
- Unmodified (53)
- Phospho-specific (12)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- Phospho T235 (1)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
Protein Source
Assay Types
Assay Platforms
Mammalian Cell Selection
Families
Pathways
- Graft-versus-host disease (706)
- Cytokine-cytokine receptor interaction (595)
- Type I diabetes mellitus (538)
- Hematopoietic cell lineage (514)
- Allograft rejection (462)
- Antigen processing and presentation (455)
- NOD-like receptor signaling pathway (406)
- Autoimmune thyroid disease (378)
- Cell adhesion molecules (CAMs) (378)
- Viral myocarditis (378)
- Cytosolic DNA-sensing pathway (358)
- Toll-like receptor signaling pathway (331)
- Asthma (328)
- Systemic lupus erythematosus (328)
- Hypertrophic cardiomyopathy (HCM) (252)
- Apoptosis (245)
- Jak-STAT signaling pathway (245)
- Prion diseases (244)
- MAPK signaling pathway (221)
- Natural killer cell mediated cytotoxicity (186)
- Pathways in cancer (168)
- Amyotrophic lateral sclerosis (ALS) (166)
- Endocytosis (134)
- Alzheimer's disease (130)
- Adipocytokine signaling pathway (86)
- Dilated cardiomyopathy (84)
- Fc epsilon RI signaling pathway (84)
- RIG-I-like receptor signaling pathway (84)
- T cell receptor signaling pathway (84)
- TGF-beta signaling pathway (84)
- Type II diabetes mellitus (84)
- Primary immunodeficiency (25)
- Long-term depression (24)
- Melanogenesis (24)
- Purine metabolism (23)
- Pyrimidine metabolism (23)
- RNA degradation (14)
- Spliceosome (2)